FindTrial
Sign In

A prospective and retrospective study to assess effectiveness and side effects of the pain control drugs in the management of post operative pain following minimally invasive surgeries of the food pipe.

An ambi-directional observational study to find out the efficacy and side effect profile of analgesic modalities used in minimally invasive esophagectomy (MIE) surgeries at a tertiary care cancer centre.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043549
Enrollment
150
Registered
2022-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the adult patients undergoing minimally invasive esophagectomy surgery at Tata Memorial Hospital.

Exclusion criteria

Exclusion criteria: Refusal of consent, emergency surgeries, inoperability after exploration, conversion to open approach, and performing any other procedure in addition to esophagectomy.

Design outcomes

Primary

MeasureTime frame
Numerical Rating Scale pain score on first 4 postoperative daysTimepoint: Numerical Rating Scale pain score on first 4 postoperative days—

Secondary

MeasureTime frame
Clavien Dindo score for post operative complicationsTimepoint: at the time of discharge from the hospital;Occurrence of side effectsTimepoint: Morning (8-12pm) and evening (6-10pm) on first 4 postoperative days;Post-operative Hospital StayTimepoint: At the time of discharge from the hospital—

Countries

India

Contacts

Public ContactDr Snehal Mahatme

Tata Memorial Hospital

swapnil.parab@gmail.com022-24177053

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026